19Jul/13

What Does Celgene Corporation (CELG)'s Failed Trial Mean for Investors? – Insider Monkey (blog)


Insider Monkey (blog)

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Insider Monkey (blog)
Biogen Idec Inc (NASDAQ:BIIB) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs

and more »

19Jul/13

Desperate Buyers, Desperate Sellers Drive Global Black Market In Human Organs – Mintpress News

Desperate Buyers, Desperate Sellers Drive Global Black Market In Human Organs
Mintpress News
While the U.S. has legal organ donation and transplant procedures, those with the power of a large bank account are trying to remedy their health problems faster by obtaining an organ replacement themselves through the black market. “Organ

and more »